drugset / Trial / NCT00171457

The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.

NCT00171457

Phase 3 Completed 24 enrolled Novartis
RandomizedCrossoverDouble-blindTreatment

Summary

Investigate the role of tegaserod in modulating gastric sensitivity to mechanical distention of the stomach

Timeline

Start
2005-04
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Tegaserod Small molecule 6 mg

Indications